A detailed history of Alera Investment Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Alera Investment Advisors, LLC holds 5,793 shares of ABBV stock, worth $982,666. This represents 0.14% of its overall portfolio holdings.

Number of Shares
5,793
Previous 5,370 7.88%
Holding current value
$982,666
Previous $921,000 24.21%
% of portfolio
0.14%
Previous 0.11%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $69,304 - $84,316
423 Added 7.88%
5,793 $1.14 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $331,714 - $387,368
2,143 Added 66.41%
5,370 $921,000
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $57,215 - $65,191
358 Added 12.48%
3,227 $587,000
Q4 2023

Jan 23, 2024

BUY
$137.6 - $154.97 $4,816 - $5,423
35 Added 1.24%
2,869 $444,000
Q3 2023

Oct 11, 2023

SELL
$133.59 - $154.65 $18,168 - $21,032
-136 Reduced 4.58%
2,834 $422,000
Q2 2023

Jul 26, 2023

SELL
$132.51 - $164.9 $68,242 - $84,923
-515 Reduced 14.78%
2,970 $400,000
Q1 2023

May 01, 2023

SELL
$144.61 - $166.54 $51,914 - $59,787
-359 Reduced 9.34%
3,485 $555,000
Q4 2022

Feb 02, 2023

BUY
$138.31 - $165.87 $16,320 - $19,572
118 Added 3.17%
3,844 $621,000
Q3 2022

Nov 09, 2022

BUY
$134.21 - $153.93 $11,676 - $13,391
87 Added 2.39%
3,726 $500,000
Q2 2022

Aug 08, 2022

BUY
$137.62 - $174.96 $109,683 - $139,443
797 Added 28.04%
3,639 $557,000
Q1 2022

May 10, 2022

BUY
$131.98 - $163.75 $375,087 - $465,377
2,842 New
2,842 $461,000
Q2 2019

Aug 07, 2019

SELL
$65.7 - $83.98 $119,968 - $153,347
-1,826 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $2.13 Million - $2.51 Million
-27,645 Reduced 93.8%
1,826 $147,000
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $2.29 Million - $2.83 Million
29,471 New
29,471 $2.72 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $300B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Alera Investment Advisors, LLC Portfolio

Follow Alera Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alera Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alera Investment Advisors, LLC with notifications on news.